Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Clostridioides difficile spore proteins are a specialized set of proteins that constitute the protective layers and germination machinery of C. difficile spores (UniProt). These proteins, including the germination receptor CspC, the cortex-lytic enzyme SleC, and the exosporium protein BclA, are fundamental to the pathogen's life cycle and its ability to cause disease (Francis et al., 2013; Adams et al., 2013). CspC is particularly significant as it senses host bile acids to initiate the transition from a dormant spore to an active, toxin-producing vegetative cell (Nature, 2013). BclA and other surface proteins facilitate the adherence of spores to the intestinal mucosa, aiding in colonization and persistence (Phetcharaburanin et al., 2014). Since spores are the primary vehicle for transmission and are highly resistant to standard antibiotics, targeting these proteins is a promising strategy for developing anti-virulence therapies (PubMed). Such therapies aim to prevent the recurrence of C. difficile infection (CDI) by blocking germination or promoting immune-mediated clearance. Current research focuses on small molecule inhibitors of CspC and vaccine candidates targeting the exosporium to break the cycle of infection (Bhattacharjee et al., 2016). These targets are distinct from traditional antibiotics as they do not necessarily kill the bacteria but prevent their activation and colonization.
Inhibition of the CspC bile acid receptor to prevent spore germination; Inhibition of the SleC protease to block cortex degradation; Antibody-mediated neutralization of exosporium proteins like BclA to prevent host cell attachment (Francis et al., 2013; Adams et al., 2013; Phetcharaburanin et al., 2014).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Clostridioides difficile spore protein (C. difficile spore protein).